Synthesis and SAR of 1,4,5,6-tetrahydropyridazines as potent cannabinoid CB1 receptor antagonists

被引：46

作者：

Lange, Jos H. M. ^{[1
]}

den Hartog, Arnold P. ^{[1
]}

van der Neut, Martina A. W. ^{[1
]}

van Vliet, Bernard J. ^{[1
]}

Kruse, Chris G. ^{[1
]}

机构：

[1] Solvay Pharmaceut, Chem Design & Synth Unit, Res Labs, NL-1381 CP Weesp, Netherlands

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 19期

关键词：

Cannabinoid CB1; Antagonist; Inverse agonist; Scaffold hopping; Tetrahydropyridazine; MOLECULAR MODELING INVESTIGATIONS; ENDOCANNABINOID SYSTEM; BIOLOGICAL-PROPERTIES; INVERSE AGONISTS; LATEST ADVANCES; IMIDAZOLE; 3,4-DIARYLPYRAZOLINES; RECOGNITION; DERIVATIVES; INHIBITORS;

D O I：

10.1016/j.bmcl.2009.08.007

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The synthesis and structure-activity relationship studies of 1,4,5,6-tetrahydropyridazines are described. The target compounds 3-5 represent a novel class of potent and selective CB1 receptor antagonists. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：5675 / 5678

页数：4

共 27 条

[11] Novel 3,4-diarylpyrazolines as potent cannabinoid CB1 receptor antagonists with lower lipophilicity [J].

Lange, JHM ;

van Stuivenberg, HH ;

Veerman, W ;

Wals, HC ;

Stork, B ;

Coolen, HKAC ;

McCreary, AC ;

Adolfs, TJP ;

Kruse, CG .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (21) :4794-4798

[12] Bioisosteric replacements of the pyrazole moiety of rimonabant:: Synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists [J].

Lange, JHM ;

van Stuivenberg, HH ;

Coolen, HKAC ;

Adolfs, TJP ;

McCreary, AC ;

Keizer, HG ;

Wals, HC ;

Veerman, W ;

Borst, AJM ;

de Looff, W ;

Verveer, PC ;

Kruse, CG .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) :1823-1838

[13] Medicinal chemistry strategies to CB1 cannabinoid receptor antagonists [J].

Lange, JHM ;

Kruse, CG .

DRUG DISCOVERY TODAY, 2005, 10 (10) :693-702

[14]

Lange JHM, 2004, CURR OPIN DRUG DISC, V7, P498

[15] Synthesis, biological properties, and molecular modeling investigations of novel 3,4-diarylpyrazolines as potent and selective CB1 cannabinoid receptor antagonists [J].

Lange, JHM ;

Coolen, HKAC ;

van Stuivenberg, HH ;

Dijksman, JAR ;

Herremans, AHJ ;

Ronken, E ;

Keizer, HG ;

Tipker, K ;

McCreary, AC ;

Veerman, W ;

Wals, HC ;

Stork, B ;

Verveer, PC ;

den Hartog, AP ;

de Jong, NMJ ;

Adolfs, TJP ;

Hoogendoorn, J ;

Kruse, CG .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (03) :627-643

[16] Cannabinoid CB1 receptor antagonists in therapeutic and structural perspectives [J].

Lange, Jos H. M. ;

Kruse, Chris G. .

CHEMICAL RECORD, 2008, 8 (03) :156-168

[17] STRUCTURE OF A CANNABINOID RECEPTOR AND FUNCTIONAL EXPRESSION OF THE CLONED CDNA [J].

MATSUDA, LA ;

LOLAIT, SJ ;

BROWNSTEIN, MJ ;

YOUNG, AC ;

BONNER, TI .

NATURE, 1990, 346 (6284) :561-564

[18] Latest advances in cannabinoid receptor antagonists and inverse agonists [J].

Muccioli, Giulio G. ;

Lambert, Didier M. .

EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (10) :1405-1423

[19] MOLECULAR CHARACTERIZATION OF A PERIPHERAL RECEPTOR FOR CANNABINOIDS [J].

MUNRO, S ;

THOMAS, KL ;

ABUSHAAR, M .

NATURE, 1993, 365 (6441) :61-65

[20] Synthesis and activity of 4,5-diarylimidazoles as human CB1 receptor inverse agonists [J].

Plummer, CW ;

Finke, PE ;

Mills, SG ;

Wang, JY ;

Tong, XC ;

Doss, GA ;

Fong, TM ;

Lao, JZ ;

Schaeffer, MT ;

Chen, J ;

Shen, CP ;

Stribling, DS ;

Shearman, LP ;

Strack, AM ;

Van der Ploeg, LHT .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (05) :1441-1446

← 1 2 3 →